Contraceptive Market Size, Share & Trends Report, 2034
Contraceptive Market - By Product (Oral Contraceptive Pills, Topical Contraceptive Pills, Injectable Contraceptive Pills, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, and Intra-Uterine Devices)By Gender (Male and Female), By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, Online Channels, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis, And Forecast, 2025 - 2034
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 31.37 Billion | USD 56.59 Billion | 6.1% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Contraceptive Market, 2016–2026 (USD Billion)
- 2.2. Contraceptive Market: Snapshot
- Chapter 3. Contraceptive Market – Industry Analysis
- 3.1. Contraceptive Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Increasing prevalence of sexually transmitted infections
- 3.3. Restraints
- 3.3.1. Increasing prevalence of side effects due to improper use of contraception products
- 3.4. Opportunity
- 3.4.1. Untapped market like developing countries and increasing medical tourism
- 3.5. Porter’s Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Method Type
- 3.6.2. Market attractiveness analysis by Region
- Chapter 4. Contraceptive Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Contraceptive Market: company market share, 2016
- 4.1.2. Global Contraceptive Market: company market share, 2017
- 4.1.3. Global Contraceptive Market: company market share, 2018
- 4.1.4. Global Contraceptive Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Method Type launches
- 4.2.3. Agreements, partnerships, cullaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Contraceptive Market –Method Type Analysis
- 5.1. Global Contraceptive Market overview: By Method Type
- 5.1.1. Global Contraceptive Market share, By Method Type, 2019 and 2026
- 5.2. Contraceptive Pills
- 5.2.1. Global Contraceptive Market by Contraceptive Pills, 2016–2026 (USD Billion)
- 5.3. Injectables
- 5.3.1. Global Contraceptive Market by Injectables, 2016–2026 (USD Billion)
- 5.4. Female Sterilization
- 5.4.1. Global Contraceptive Market by Female Sterilization, 2016–2026 (USD Billion)
- 5.5. Intrauterine Devices & Systems
- 5.5.1. Global Contraceptive Market by Intrauterine Devices & Systems, 2016–2026 (USD Billion)
- 5.6. Male Condom
- 5.6.1. Global Contraceptive Market by Male Condom, 2016–2026 (USD Billion)
- 5.7. Emergency Contraception
- 5.7.1. Global Contraceptive Market by Emergency Contraception, 2016–2026 (USD Billion)
- 5.8. Other
- 5.8.1. Global Contraceptive Market by others, 2016–2026 (USD Billion)
- 5.1. Global Contraceptive Market overview: By Method Type
- Chapter 6. Global Contraceptive Market - Regional Analysis
- 6.1. Global Contraceptive Market overview: by Region
- 6.1.1. Global Contraceptive Market share, by Region, 2019 and 2026
- 6.2. North America
- 6.2.1. North America Contraceptive Market, 2016–2026 (USD Billion)
- 6.2.2. North America Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.2.3. The U.S.
- 6.2.3.1. The U.S. Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.2.4. The U.S.
- 6.2.4.1. The U.S. Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.2.5. Canada
- 6.2.5.1. Canada Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.2.6. Mexico
- 6.2.6.1. Mexico Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.3 Europe
- 6.3.1 Europe Contraceptive Market, 2016–2026 (USD Billion)
- 6.3.2 Europe Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.3.3 UK
- 6.3.3.1 U.K. Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.3.4 France
- 6.3.4.1 France Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.3.5 Germany
- 6.3.5.1 Germany Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.3.6 Rest of Europe
- 6.3.6.1 Rest of Europe Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.4 Asia Pacific
- 6.4.1 Asia Pacific Contraceptive Market, 2016–2026 (USD Billion)
- 6.4.2 Asia Pacific Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.4.3 China
- 6.4.3.1 China Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.4.4 Japan
- 6.4.4.1 Japan Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.4.5 India
- 6.4.5.1 India Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.4.6 Rest of Asia Pacific
- 6.4.6.1 Rest of Asia Pacific Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.5 Latin America
- 6.5.1 Latin America Contraceptive Market, 2016–2026 (USD Billion)
- 6.5.2 Latin America Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.5.3 Brazil
- 6.5.3.1 Brazil Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.5.4 Rest of Latin America
- 6.5.4.1 Rest of Latin America Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.6 The Middle East and Africa
- 6.6.1 The Middle East and Africa Contraceptive Market, 2016–2026 (USD Billion)
- 6.6.2 The Middle East and Africa Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
- 6.1. Global Contraceptive Market overview: by Region
- Chapter 7 Company Profiles
- 7.3 The Female Health Company
- 7.3.1 Overview
- 7.3.2 Financials
- 7.3.3 Method Type Portfolio
- 7.3.4 Business Strategy
- 7.3.5 Recent Developments
- 7.4 Teva Pharmaceutical Industries
- 7.4.1 Overview
- 7.4.2 Financials
- 7.4.3 Method Type Portfolio
- 7.4.4 Business Strategy
- 7.4.5 Recent Developments
- 7.5 Bayer Healthcare Pharmaceuticals
- 7.5.1 Overview
- 7.5.2 Financials
- 7.5.3 Method Type Portfolio
- 7.5.4 Business Strategy
- 7.5.5 Recent Developments
- 7.6 Piramal Healthcare Limited
- 7.6.1 Overview
- 7.6.2 Financials
- 7.6.3 Method Type Portfolio
- 7.6.4 Business Strategy
- 7.6.5 Recent Developments
- 7.7 Reckitt Benckiser Plc.
- 7.7.1 Overview
- 7.7.2 Financials
- 7.7.3 Method Type Portfolio
- 7.7.4 Business Strategy
- 7.7.5 Recent Development
- 7.8 Cipla Limited
- 7.8.1 Overview
- 7.8.2 Financials
- 7.8.3 Method Type Portfolio
- 7.8.4 Business Strategy
- 7.8.5 Recent Development
- 7.9 Novartis AG
- 7.9.1 Overview
- 7.9.2 Financials
- 7.9.3 Method Type Portfolio
- 7.9.4 Business Strategy
- 7.9.5 Recent Development
- 7.10 Lupin Pharmaceuticals, Inc.
- 7.10.1 Overview
- 7.10.2 Financials
- 7.10.3 Method Type Portfolio
- 7.10.4 Business Strategy
- 7.10.5 Recent Development
- 7.11 Pfizer, Inc.
- 7.11.1 Overview
- 7.11.2 Financials
- 7.11.3 Method Type Portfolio
- 7.11.4 Business Strategy
- 7.11.5 Recent Development
- 7.12 Amgen Inc.
- 7.12.1 Overview
- 7.12.2 Financials
- 7.12.3 Method Type Portfolio
- 7.12.4 Business Strategy
- 7.12.5 Recent Development
- 7.3 The Female Health Company
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Contraceptive Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Contraceptive Market attractiveness, By Method Type
6. Global Contraceptive market share, By Method Type, 2019 and 2026
7. Global Contraceptive Market by Contraceptive Pills, 2016–2026 (USD Billion)
8. Global Contraceptive Market by Injectables, 2016–2026 (USD Billion)
9. Global Contraceptive Market by Female Sterilization, 2016–2026 (USD Billion)
10. Global Contraceptive Market by Intrauterine Devices & Systems,2016–2026 (USD Billion)
11. Global Contraceptive Market by Male Condom, 2016–2026 (USD Billion)
12. Global Contraceptive Market by Emergency Contraception, 2016–2026 (USD Billion)
13. Global Contraceptive Market by Other,2016–2026 (USD Billion)
14. Global Contraceptive Market share, by Region, 2018and 2026
15. North America Contraceptive Market, 2016–2026 (USD Billion)
16. Europe Contraceptive Market, 2016–2026 (USD Billion)
17. Asia Pacific Contraceptive Market, 2016–2026 (USD Billion)
18. Latin America Contraceptive Market, 2016–2026 (USD Billion)
19. The Middle East and Africa Contraceptive Market, 2016–2026 (USD Billion)
Table Of Tables
List of Tables
1. Global Contraceptive Market: snapshot
2. Drivers of the Contraceptive Market: impact analysis
3. Restraints of the Contraceptive Market: impact analysis
4. North America Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
5. The U.S. Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
6. Canada Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
7. Mexico Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
8. Europe Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
9. U.K. Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
10. France Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
11. Germany Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
12. Rest of Europe Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
13. Asia Pacific Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
14. China Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
15. Japan Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
16. India Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
17. Rest of Asia Pacific Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
18. Latin America Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
19. Brazil Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
20. Rest of Latin America Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
21. The Middle East and Africa Contraceptive Market revenue, By Method Type,2016–2026 (USD Billion)
Methodology
FrequentlyAsked Questions
Expansion of contraceptive market over forecast timeline is subject to growing need for reducing risk of sexually transmitted disorders and health related problems.
According to a study, the global contraceptive market size was worth around USD 31.37 Billion in 2024 and is expected to reach USD 56.59 Billion by 2034.
The global contraceptive market is expected to grow at a CAGR of 6.1% during the forecast period.
North America is expected to dominate the contraceptive market over the forecast period.
Leading players in the global contraceptive market include The Female Health Company, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Amgen Inc., Bayer Healthcare Pharmaceuticals LLC, Pfizer Inc., Piramal Healthcare Limited, Reckitt Benckiser Group PLC, Lupin Pharmaceuticals Inc., Cipla L, among others.
The report explores crucial aspects of the contraceptive market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed